Allianz Asset Management »

Keros Therapeutics shares owned by Allianz Asset Management

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Allianz Asset Management from 13F filings

Historical chart of Allianz Asset Management investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Allianz Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Allianz Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $604k 10k 58.07
2024-06-30 $407k 8.9k 45.70
2023-09-30 $389k 12k 31.88
2023-06-30 $490k 12k 40.18
2023-03-31 $521k 12k 42.70
2022-12-31 $778k 16k 48.02
2022-09-30 $685k 18k 37.64
2022-06-30 $3.5M 128k 27.63
2022-03-31 $4.1M 75k 54.38
2021-12-31 $2.8M 48k 58.50